Arrowhead Pharmaceuticals (ARWR) shares outstanding

Shares outstanding · fiscal 2026
141.29M

Arrowhead Pharmaceuticals (ARWR) had 141.29M diluted shares on average in fiscal 2026 (the year ended September 30, 2026). That is 5.6% higher than the 133.76M of fiscal 2025. Figures as of 18 Nov 2026, 12:09 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Shares outstanding, fiscal 2026
141.29M
Change on fiscal 2025
+5.6%
Growth, 5 years
+6.4% a year
Highest on record
141.29Mfiscal 2026
Lowest on record
6.43Mfiscal 2010
Fiscal years on record
132010–2026

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.

Arrowhead Pharmaceuticals shares outstanding, in more detail

The market data feed counts 141.37M shares outstanding today.

Over the five fiscal years to 2026 the diluted share count grew at a compound 6.4% a year. Across the 13 fiscal years on record (2010–2026), the highest was 141.29M in fiscal 2026 and the lowest 6.43M in fiscal 2010.

History · 13 fiscal years

Shares outstanding by fiscal year

Arrowhead Pharmaceuticals shares outstanding, year by year

Arrowhead Pharmaceuticals (ARWR) shares outstanding by fiscal year
Fiscal yearShares outstandingChangeYear ended
2026141.29M 5.6% up
2025133.76M 11.7% up
2024119.78M 11.6% up
2023107.31M 1.8% up
2022105.43M 1.6% up
2021103.75M 3.0% up
2020100.72M 2.1% up
201998.61M 17.9% up
201883.64M 13.2% up
201773.90M—
201211.13M 42.1% up
20117.83M 21.7% up
20106.43M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

The share count for each fiscal year is the diluted weighted average the company reports with its earnings per share, re-based for later stock splits; the number outstanding today comes from the market data feed.

How to read it

A falling count means buybacks are giving each remaining share a larger slice of the company; a rising one means owners are being diluted.

Shares outstanding at health care companies of similar size

Shares outstanding of Arrowhead Pharmaceuticals and comparable companies
CompanyShares outstandingFiscal year
Axsome Therapeutics AXSM49.75M2025
Chemed CHE14.46M2025
Oruka Therapeutics ORKA45.61M2025
Arrowhead Pharmaceuticals ARWR141.29M2026
MSA Safety MSA39.35M2025
CG Oncology CGON77.30M2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on ARWR

Arrowhead Pharmaceuticals, figure by figure

Arrowhead Pharmaceuticals (ARWR) overview: price, valuation and scorecardAll health care companies by market value

Arrowhead Pharmaceuticals shares outstanding: questions and answers

How many shares does Arrowhead Pharmaceuticals have?

Arrowhead Pharmaceuticals (ARWR) had 141.29M diluted shares on average in fiscal 2026 (the year ended September 30, 2026). That is 5.6% higher than the 133.76M of fiscal 2025. The market data feed counts 141.37M shares outstanding today.

What is the growth rate of Arrowhead Pharmaceuticals's diluted share count?

Over the five fiscal years to 2026 the diluted share count grew at a compound 6.4% a year.

What are the highest and lowest diluted share count figures on record for Arrowhead Pharmaceuticals?

Across the 13 fiscal years on record (2010–2026), the highest was 141.29M in fiscal 2026 and the lowest 6.43M in fiscal 2010.

How is Arrowhead Pharmaceuticals's diluted share count calculated?

The share count for each fiscal year is the diluted weighted average the company reports with its earnings per share, re-based for later stock splits; the number outstanding today comes from the market data feed. For Arrowhead Pharmaceuticals it is on record here for 13 fiscal years, 2010 to 2026.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Arrowhead Pharmaceuticals (ARWR) shares outstanding”, data as of 18 November 2026. https://funkfolio.com/stock/ARWR/shares-outstanding

Underlying data: the company's filings with the SEC and Yahoo Finance.